gamma-Hydroxy-1,N(2)-propano-2'deoxyguanosine (
gamma-HOPdG) is a major
deoxyguanosine adduct derived from
acrolein, a known
mutagen. In vitro, this adduct has previously been shown to pose a severe block to translesion synthesis by a number of polymerases (pol). Here we show that both yeast and human pol eta can incorporate a C opposite
gamma-HOPdG at approximately 190- and approximately 100-fold lower efficiency relative to the control
deoxyguanosine and extend from a C paired with the adduct at approximately 8- and approximately 19-fold lower efficiency. Although
DNA synthesis past
gamma-HOPdG by yeast pol eta was relatively accurate, the human
enzyme misincorporated
nucleotides opposite the lesion with frequencies of approximately 10(-1) to 10(-2). Because
gamma-HOPdG can adopt both ring closed and ring opened conformations, comparative replicative bypass studies were also performed with two model adducts, propanodeoxyguanosine and reduced
gamma-HOPdG. For both yeast and human pol eta, the ring open reduced
gamma-HOPdG adduct was less blocking than
gamma-HOPdG, whereas the ring closed propanodeoxyguanosine adduct was a very strong block. Replication of DNAs containing
gamma-HOPdG in wild type and
xeroderma pigmentosum variant cells revealed a somewhat decreased mutation frequency in
xeroderma pigmentosum variant cells. Collectively, the data suggest that pol eta might potentially contribute to both error-free and mutagenic bypass of
gamma-HOPdG.